enVVeno Medical (NVNO) Free Cash Flow (2017 - 2026)

enVVeno Medical's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$3.2 million for Q1 2026.

• On a quarterly basis, Free Cash Flow rose 19.41% year-over-year to -$3.2 million in Q1 2026; TTM through Mar 2026 was -$14.8 million, a 14.68% increase from a year earlier, with the FY2025 full-year figure at -$15.6 million, up 7.72% from the prior year.
• Free Cash Flow grew to -$3.2 million in Q1 2026 per NVNO's latest filing, from -$3.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$3.2 million in Q1 2026 and bottomed at -$5.1 million in Q1 2023.
• The 5-year median for Free Cash Flow is -$4.0 million (2025), against an average of -$4.1 million.
• Across the five-year window, Free Cash Flow plunged 88.55% in 2022 and surged 32.61% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$3.9 million in 2022, then declined by 28.77% to -$5.0 million in 2023, then slipped by 2.65% to -$5.1 million in 2024, then soared by 32.61% to -$3.4 million in 2025, then climbed by 5.95% to -$3.2 million in 2026.
• Per Business Quant, the three latest NVNO Free Cash Flow figures stand at -$3.2 million (Q1 2026), -$3.4 million (Q4 2025), and -$4.4 million (Q3 2025).